States of HIV
Disparities in HIV treatment initiation, viral load suppression vary across U.S.

Under Pressure
Hypertension greater heart attack risk in people with HIV.

Puffers Beware
HIV speeds lung function decline in study of mostly cigarette smokers.

Block that CCR5
Sangamo gene therapy continues to show well in Phase I studies.

Head to Head
All-in-one Quad tablet comparable to leading combo tablet Atripla.

Rear Results
A modified tenofovir gel safe and acceptable for rectal use in microbicide study.

Adherence Matters Most
Poor compliance hurts PrEP efficacy in high-risk women.

Breath Easy
Inhaled steroid for asthma & COPD found safe in combo with PIs.

Safe Shot
Shingles vaccine proves safe in people living with HIV and stable labs.

One Liver to Love
ARV liver toxicity in HIV/hep C patients on the decline.

Metformin Does Arteries Good
Diabetes medication halts plaque buildup in blood vessels.

Brain Drain
Minor cognitive problems can lead to daily functioning problems, study says.

Dolutegravir vs. Sustiva
ViiV's integrase comparable to a gold standard in treatment newbies.

Help for Hep
Incivek, Victrelis improve cure rates in HIV, hep C coinfection studies.

Antigen Answer
Drop in active hep B infection marker seen in tenofovir takers .

Tenofovir Part II
New tenofovir prodrug packs better, potentially safer punch vs. Viread.

Double Death Trouble
Black women twice as likely to die of AIDS in U.S. vs. white women.

Chemo Cure?
Anti-cancer drug Zolinza purges HIV from its hiding place.

Hepatitis Hiccup
12-week 7977/ribavirin course not enough for hep C geno 1 null responders.

Prevention for Partners
PrEP a success for hetero mixed-status couples.

On the Agenda
David Evans highlights a pre-CROI meeting to refine the role of activists in cure research strategies.